12 employees
CytaCoat is developing a new technology of antibacterial coating for medical devices.
2001
$84K
from 2 investors over 2 rounds
CytaCoat raised undisclosed on October 1, 2020
Investors: Segulah Medical Acceleration
CytaCoat raised $84K on August 1, 2018
Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)